Anavex Life Sciences Corp (AVXL)

[nidan7500]

11:25 eastern time 04/26/18

Empowered educated patients influencing pre-clinical development and working with industry to optimize drug discovery

Rare Disease Advocacy World
Patient groups role guiding research, disease understanding, supporting pre-clinical development and follow up experiments
Driving translational research and the influence on formulation, routes to delivery and overall clinical development
Effective partnerships between advocacy and industry to expand collaborations that can support enrollment and physician engagement

Christopher Missling,
President and CEO,
Anavex Life Sciences

Steven Kaminsky,
Chief Science Officer,
International Rett Syndrome Foundation